Clinical Trials Logo

Mental Disorders clinical trials

View clinical trials related to Mental Disorders.

Filter by:

NCT ID: NCT00232349 Terminated - Schizophrenia Clinical Trials

Efficacy of Galantamine to Treat Schizophrenia

Start date: February 2005
Phase: Phase 4
Study type: Interventional

The purpose of this study was to determine if treatment with adjunctive galantamine is effective in the reduction of functional impairments in patients with schizophrenia and schizoaffective disorder. It was hypothesized that adjunctive galantamine would yield clinically significant improvements from baseline to end of study on a measure of quality of life and a measure of independent living skills.

NCT ID: NCT00231933 Completed - Psychotic Disorders Clinical Trials

Culturally Responsive Person-Centered Care for Psychosis

Start date: October 2005
Phase: Phase 1
Study type: Interventional

This study will compare standard individualized care to person-centered care and community-integrating care for treating psychosis in adults of Hispanic or African descent.

NCT ID: NCT00226278 Completed - Clinical trials for Major Depressive Disorder

Safety Study of ORG 34517 for Major Depression With Psychotic Features

Start date: September 2004
Phase: Phase 2
Study type: Interventional

Patients suffering from Major Depressive Disorder with Psychotic features who have received no changes in their medications in the previous two weeks will receive "usual" treatment of antidepressants, antipsychotics and/or mood stabilizers and adjunct therapy using ORG34517. The patient will be hospitalized for up to two weeks to monitor their medications and progress and will return to the site for periodic assessments.

NCT ID: NCT00224302 Completed - Psychotic Disorders Clinical Trials

Treatment of MDEs During the Course of Psychotic Disorders With Duloxetine

Start date: August 2005
Phase: Phase 4
Study type: Interventional

We evaluate the efficacy and tolerability of duloxetine in the treatment of major depressive episodes during the course of psychotic disorders

NCT ID: NCT00222495 Completed - Schizophrenia Clinical Trials

A Comparative Study of New Medications for Psychosis in Adolescents

Start date: August 2002
Phase: N/A
Study type: Interventional

The overall goal of this study is to determine the efficacy and tolerability of three atypical antipsychotic medications (risperidone, olanzapine, and quetiapine) in the treatment of adolescents with psychosis. It is hypothesized that the three medications will be equally effective in reducing the symptoms of psychosis.

NCT ID: NCT00218582 Completed - Clinical trials for Substance-Related Disorders

Effectiveness of Self-Help for Dually-Diagnosed Persons - 1

Start date: March 2003
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this study is to determine the effectiveness of adding dual focus 12-step self-help groups to standard treatment to improve behavioral outcomes for patients dually diagnosed with substance abuse and psychiatric disorders.

NCT ID: NCT00218114 Completed - Marijuana Abuse Clinical Trials

Divalproex Sodium (Depakote) for Explosive Tempers in Adolescents and Adults

Start date: February 2000
Phase: Phase 3
Study type: Interventional

The purpose of this study is to compare the effectiveness of divalproex sodium (Depakote) versus placebo in treating disruptive behavior disorder and explosive tempers in adolescents and adults.

NCT ID: NCT00216632 Completed - Schizophrenia Clinical Trials

A Study of Treatment Success in Changing From Olanzapine to Long-acting Injectable Risperidone (RISPERDAL® CONSTA™)

Start date: March 2005
Phase: Phase 4
Study type: Interventional

The purpose of the study is to evaluate the maintained effectiveness of long-acting injectable risperidone (RISPERDAL® CONSTA™) compared with the previous treatment with oral olanzapine in non-acute subjects with schizophrenia or schizoaffective disorder considered in need of a therapy change.

NCT ID: NCT00216502 Completed - Alzheimer Disease Clinical Trials

A Study of the Safety and Effectiveness of Galantamine in Patients With Alzheimer's Disease

Start date: August 2001
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the long-term efficacy and safety of galantamine in patients with Alzheimer's disease.

NCT ID: NCT00216476 Completed - Schizophrenia Clinical Trials

A Study of Relapse Prevention and the Effectiveness of Long-acting Injectable Risperidone and Quetiapine Tablets in the Treatment of Patients With Schizophrenia or Schizoaffective Disorder

Start date: October 2004
Phase: Phase 3
Study type: Interventional

The purpose of this study is to investigate whether a long-acting injectable formulation of risperidone provides better effectiveness over 2 years, as measured by the time to relapse, compared with quetiapine tablets in a routine psychiatric care setting. Aripiprazole will be investigated in a descriptive manner.